IN BRIEF: MaxCyte chief scientific officer leaves firm
MaxCyte Inc - Maryland, US-based provider of cell engineering platform technologies developing ‘next-generation cell therapeutics’ - Announces departure of Cenk Sumen as chief scientific officer,...
Mon, 29/01/2024 - 17:56